WVENasdaqPharmaceutical PreparationsFiscal year ends December 31
Wave Life Sciences, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 30, 2026
$3.17+0.04 (+1.28%)
Close on Oct 19, 2026
- Market cap
- $646.71M
- P/E (TTM)
- –
- Dividend yield
- –
Dividends
Wave Life Sciences has not reported a dividend
No dividend per share appears in Wave Life Sciences's annual filings since fiscal 2012.